Category: Pharma & drug development
Are the rules being tightened on pharma M&A?
Academic-industry collaboration
Regenerative medicine: ready for the big leagues?
Antibiotic adjacent: the alternatives tackling AMR
Logging in: how the pharma industry is getting to grips with social media
How radiopharmaceuticals are helping fight cancer with Fusion
Competition heats up as new HIV drug shows promise
Saxenda: profiling the first NHS weight loss drug for a decade
Is self-medication the future of pharma?
Could CRISPR reinvent the Covid-19 test?
Q&A: delivering a billion vaccine doses
LexaGene’s new automated testing platform
Special delivery: the logistics of curing Covid-19
Q&A: Atomwise’s journey from discoverer to developer
The rise of gout: examining drug development for an age-old disease
Catching cancer: could a new blood test rewrite oncology?
Oxytocin: the therapeutic potential of the ‘love hormone’
Crabby concoctions: Why pharma’s thirst for crustacean blood is up for debate
